Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Rare Variants in Antisense Long Noncoding RNA-Protein-Coding Gene Overlap Regions Contribute to Obsessive-Compulsive Disorder

Summarise with AI (MRCPsych/FRANZCP)

Biol Psychiatry Glob Open Sci. 2025 Dec 23;6(2):100683. doi: 10.1016/j.bpsgos.2025.100683. eCollection 2026 Mar.

ABSTRACT

BACKGROUND: Obsessive-compulsive disorder (OCD) is a prevalent neuropsychiatric disorder with an incompletely understood genetic basis, limiting targeted therapeutic options. Although previous rare-variant studies have primarily focused on protein-coding genes, the contribution of rare regulatory noncoding variants remains largely unexplored.

METHODS: We analyzed whole-genome sequencing data from 2561 OCD cases and 12,974 controls from the All of Us Research Program to investigate rare conserved variants within 992 genomic regions where antisense long noncoding RNAs (lncRNAs) overlap protein-coding genes, using both Fisher’s exact test and the Optimal Sequence Kernel Association Test for association testing.

RESULTS: We identified significant enrichment of rare conserved variants in the KNCN/MKNK1-AS1 overlap region in OCD cases (odds ratio = 5.1, false discovery rate < .05). This enrichment was significant in overlapping regions of genes with low evolutionary constraint. Expression analysis revealed strong coexpression of KNCN and MKNK1-AS1 specifically in striatal brain regions (nucleus accumbens: r = 0.83, putamen: r = 0.81, caudate: r = 0.79)-key components of circuits disrupted in OCD. Genes coexpressed with this regulatory pair were enriched for synaptic vesicle dynamics, calcium signaling, and established OCD risk genes from genome-wide association studies (false discovery rate < .05).

CONCLUSIONS: These results highlight the importance of rare noncoding regulatory variation in OCD genetics. The association of KNCN/MKNK1-AS1 variants with OCD suggests that antisense lncRNA-protein-coding overlap regions may contribute to disease susceptibility and represent potential therapeutic targets.

PMID:41675975 | PMC:PMC12887771 | DOI:10.1016/j.bpsgos.2025.100683

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD